Microbot Medical(DE:CY9D)
€0.98+0.05 (+4.95%)
DE:CY9D
Microbot Medical stock forecast
€0.98
At close:+0.05 (+4.95%)
Microbot Medical (CY9D) Stock Forecast & Price Target
1 Followers
CY9D Analyst Ratings
Strong Buy
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Microbot Medical in the past 3 months
CY9D Stock 12 Month Forecast
Average Price Target
€4.84▲(396.29% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Microbot Medical in the last 3 months. The average price target is EUR 4.84 with a high forecast of EUR 10.81 and a low forecast of EUR 2.25. The average price target represents a 396.29% change from the last price of EUR 0.98.
Past 12 Months12 Month ForecastJan2026Oct2026
High€10.81
Average€4.84
Low€2.25
Highest Price TargetHighest€10.81Average Price Target€4.84Lowest Price TargetLowest€2.25
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ram Selvaraju | H.C. Wainwright | €10.81 | buy | 1008.01%Upside | Reiterated | 10/28/26 | ||
| Daniel Stauder | Citizens JMP | €2.25 | buy | 130.83%Upside | Initiated | 10/23/26 | ||
| Alexander Nowak | Lucid Capital | €3.60→€2.70 | buy | 177.00%Upside | Reiterated | 09/25/26 | ||
| William Wood | B. Riley Securities | €3.60 | buy | 269.34%Upside | Initiated | 09/11/26 | ||
| Kyle Bauser | Titan Partners | €4.96 | buy | 407.84%Upside | Reiterated | 04/14/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ram SelvarajuH.C. Wainwright | BuyReiterated€10.81 | 10/28/26 | 1008.01%Upside | ||
| Daniel StauderCitizens JMP | BuyInitiated€2.25 | 10/23/26 | 130.83%Upside | ||
| Alexander NowakLucid Capital | BuyReiterated€3.60→€2.70 | 09/25/26 | 177.00%Upside | ||
| William WoodB. Riley Securities | BuyInitiated€3.60 | 09/11/26 | 269.34%Upside | ||
| Kyle BauserTitan Partners | BuyReiterated€4.96 | 04/14/26 | 407.84%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Microbot Medical
3 Months
Success Rate3/11 ratings generated profit
27%
Average Return
-18.66%
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of -18.66% per trade.
1 Year
Success Rate1/11 ratings generated profit
9%
Average Return
-40.59%
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -40.59% per trade.
2 Years
Success Rate1/11 ratings generated profit
9%
Average Return
-47.56%
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 9.09% of your transactions generating a profit, with an average return of -47.56% per trade.
CY9D Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 6 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 3 | 4 | 6 | 5 |
In the current month, CY9D has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CY9D average Analyst price target in the past 3 months is 4.84.
CY9D Financial Forecast
CY9D Stock Forecast FAQ
What is DE:CY9D’s average 12-month price target, according to analysts?
Based on analyst ratings, Microbot Medical’s 12-month average price target is €4.84.
What is DE:CY9D’s upside potential, based on the analysts’ average price target?
Microbot Medical has 396.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Microbot Medical a Buy, Sell or Hold?
Microbot Medical has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Microbot Medical’s share price target?
The average share price target for Microbot Medical is €4.84. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €10.81, and the lowest forecast is €2.25. The average share price target represents a 396.29% increase from the current price of €0.976.
What do analysts say about Microbot Medical?
Microbot Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Microbot Medical?
To buy shares of DE:CY9D, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
